-
www.ahrq.gov/sites/default/files/2024-01/strom-report.pdf
January 01, 2024 - disease and chronic nephritis (for the renal dysfunction cohort),
and a history of alcoholism and … Renal dysfunction was defined by a READ code for acute kidney injury, chronic kidney disease, end-
stage … A secondary analysis excluded patients with a READ code for chronic kidney disease. … disease 0.5% 0.4% excluded excluded 0.5% 0.4%
Chronic kidney disease 3.4% 1.2% excluded excluded 3.4% … disease outcomes
statin 3A4 substrate + CYP3A4X 152 33,543 4.53
2.20
(1.85-2.62)
1.75
(1.46-2.08)
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide72.html
October 01, 2014 - 72. For the Patient Unwilling To Quit (Continued)
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
The "5 Rs"
Relevance
Encourage the patient to indicate why quitting is personally relevant, being as specific as possible. Motivational information has the great…
-
www.ahrq.gov/sites/default/files/publications/files/cbprbrief.pdf
January 01, 2014 - individual
interviews to provide additional
information. (6/1/2007 to 5/31/2008)
3
Making Chronic Kidney … Disease
Guidelines Work in Underserved
Practices (HS16031). … Chronic kidney
disease, a worldwide public health issue,
is four times more likely to burden
minority … assess provider- and staff-
identified barriers to implementing
evidence-based guidelines for chronic
kidney … disease in minority populations.
(6/1/2006 to 5/31/2008)
International Meeting on Indigenous
Child
-
www.ahrq.gov/cahps/surveys-guidance/ich/index.html
November 01, 2023 - CAHPS In-Center Hemodialysis Survey
The CAHPS In-Center Hemodialysis Survey asks adults with end-stage renal disease about their experiences with care from dialysis facilities. The Centers for Medicare & Medicaid Services (CMS) began national implementation of this survey in 2014. Dialysis facilities and End-St…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/hispanichealth/2014nhqdr-hispanichealth-pt2.pdf
July 01, 2015 - Keeping blood glucose
levels under control can prevent or slow the progression of kidney disease. … When kidney
disease is detected early, medication can slow the disease’s progress; when detected late … disease due to diabetes … Diseases, U.S. … Diseases, U.S.
-
www.ahrq.gov/patient-safety/settings/esrd/resource.html
January 01, 2015 - AHRQ Safety Program for End-Stage Renal Disease Facilities – Toolkit
The ESRD Toolkit was created to help end-stage renal disease clinics prevent healthcare-associated infections in dialysis patients. The toolkit helps dialysis center clinicians make care safer by following clinical best practices, creating a c…
-
www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/one-pager-clostridioides-difficile.pdf
June 01, 2021 - Management of Clostridioides Difficile Infection
Diagnosis
• Case definition: ≥3 unformed stools in a 24-hour period without an alternative explanation and a
positive stool test for C. difficile.1
• Clinical spectrum of infection ranges from watery diarrhea with lower abdominal pain, cramping, and
nausea (wit…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/apcd/apcd-inventory.xlsx
October 01, 2015 - No
Kidney or bladder disorders Chronic kidney disease (CKD) or end stage renal disease (ESRD) Quality … Process Advanced Chronic Kidney Disease (CKD): Percent of Patients With One Measurement of iPTH. … No
Kidney or bladder disorders CKD or ESRD Quality Process Adult Kidney Disease: Laboratory Testing
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/d4g_combo_psi10-postopmetaderangement-bestpractices.pdf
May 20, 2016 - Atlas of Kidney Diseases. Vol. 1. Chapter 12. Philadelphia, PA:
Wiley-Blackwell; 1999.
9.
-
www.ahrq.gov/ncepcr/reports/2024-annual-report/appendix-d.html
May 01, 2024 - Investments in Primary Care Research for 2021 and 2022
8. Appendix D: Grant Summaries
Previous Page Next Page
Table of Contents
Investments in Primary Care Research for 2021 and 2022
Acknowledgments and Authors
Message from the Acting Director of AHRQ's National Center for Excellence in Primary …
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/hispanichealth/2014nhqdr-hispanichealth-pt2.pptx
July 01, 2015 - diseases, blindness, nerve damage, and stroke. … Diseases, U.S. … Keeping blood glucose levels under control can prevent or slow the progression of kidney disease. … When kidney disease is detected early, medication can slow the disease’s progress; when detected late … disease due to diabetes.
-
www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/womenhealth/wm-ref.html
September 01, 2015 - Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review.
-
www.ahrq.gov/research/findings/final-reports/ssi/ssiapk.html
April 01, 2018 - available)
5
2
1
Diabetes
6
3
1
Chronic Lung Disease
3
2
1
Chronic Kidney … Disease
3
2
1
Peripheral vascular disease
2
1
1
Prior site irradiation (At
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-146-section-5.pdf
January 01, 2014 - educational interventions
should target areas of weakness in
adolescent knowledge.
1137.[62]
Kidney … Disease and Transplant
Cross-sectional
Survey-based; youth, young
adult, and parent report
The
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/prevhosp/sampleransferandintakenotes.pdf
June 02, 2025 - AHRQ’s Safety Program for Nursing Homes: On-Time
Preventable Hospital and Emergency Department Visits
Transfer Note and Intake Note
Transfer Notes and Intake Notes are not required, but the elements included in them must be in
the nursing home’s electronic medical record (EMR) to generate all components of the re…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/prevhosp/prevehosp-trans-intakenotes.pdf
June 02, 2025 - AHRQ’s Safety Program for Nursing Homes: On-Time Preventable Hospital and ED Visits - Transfer Note and Intake Note
AHRQ’s Safety Program for Nursing Homes: On-Time
Preventable Hospital and Emergency Department Visits
Transfer Note and Intake Note
Transfer Notes and Intake Notes are not required, but the elemen…
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/prevhosp/ereport-handouts.html
June 01, 2017 - AHRQ’s Safety Program for Nursing Homes: On-Time Preventable Hospital and Emergency Department Visits
Transfer Note and Intake Note
Transfer Notes and Intake Notes are not required, but the elements included in them must be in the nursing home’s electronic medical record (EMR) to generate all components of…
-
www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/dx-journey-presenter-notes.pdf
June 02, 2025 - TeamSTEPPS® Diagnosis Improvement: Diagnostic Journey of Mr. Kane
Slide 1
TeamSTEPPS® for Diagnosis
Improvement
The Diagnostic Journey of
Mr. Kane
Narrator: This story is about the diagnostic journey of Mr. Kane. The story
outlines several areas where communication failures led to missed and
delayed diag…
-
www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/dx-journey-mr-kane.pptx
June 02, 2025 - Journey of Mr. Kane
The Diagnostic Journey of
Mr. Kane
TeamSTEPPS® for Diagnosis Improvement
Narrator: This story is about the diagnostic journey of Mr. Kane. The story outlines several areas where communication failures led to missed and delayed diagnosis that contributed to Mr. Kane’s death. The story is told fro…
-
www.ahrq.gov/sites/default/files/2024-01/magid-report.pdf
January 01, 2024 - disease, 2) 21,000
patients who receive high-risk drugs requiring laboratory monitoring, and 3)
59,700 … This project alerted pharmacists to errors in prescribing for the
19,000 KPCO patients with chronic kidney … disease, a condition in which
medication doses frequently need to be adjusted based on kidney function … disease patients are included in the Renal Dosing project). … Improving Prescribing Safety in
Patients with Chronic Kidney Disease: A Pharmacy-Based Intervention.